Taiwan cobra phospholipase A2-elicited JNK activation is responsible for autocrine Fas-mediated cell death and modulating Bcl-2 and Bax protein expression in human leukemia K562 cells

Journal of Cellular Biochemistry

Volumn 109, Issue 1, 2010, Pages 245-254

  Chen, Ku Chung ^a   Liu, Wen Hsin ^a   Chang, Long Sen ^a  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

BCL 2 family proteins; FAS; FASL; JNK; Phospholipase A2

Indexed keywords

CASPASE 8; CYTOCHROME C; FAS ANTIGEN; FAS LIGAND; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL DEATH; CELL FRACTIONATION; CELL STRAIN K 562; CELL VIABILITY; CYTOTOXICITY; DNA TRANSFECTION; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RNA INTERFERENCE; SNAKE; TAIWAN; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL SEPARATION; CELL SURVIVAL; COBRA VENOMS; ENZYME ACTIVATION; ENZYME INHIBITORS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; K562 CELLS; LEUKEMIA; MAP KINASE KINASE 4; MEMBRANE POTENTIAL, MITOCHONDRIAL; PHOSPHOLIPASES A2; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION;

NAJA ATRA;

EID: 73849110672     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22404     Document Type: Article

References (35)

1. Asakura T, Maeda K, Omi H, Matsudaira H, Ohkawa K. 2008. The association of deamidation of Bcl-xL and translocation of Bax to the mitochondria through activation of JNK in the induction of apoptosis by treatment with GSH-conjugated DXR. Int J Oncol 33:389-395.
2. 2. J Biochem (Tokyo) 124:764-768.
3. Chang L, Kamata H, Solonas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin M. 2006. The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FILPL turnover. Cell 124:601-613.
4. Donata NJ, Wu JY, Stapley J, Lin H, Arlinghaus R, Aggarwal BB, Shishodia S, Albitar M, Hayes K, Kantarjian H, Talpaz M. 2004. Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia. Cancer Res 64:672-677.
5. Faris M, Latinis KM, Kempiak SJ, Koretzky GA, Nel A. 1998. Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter. Mol Cell Biol 18: 5414-5424.
6. Fujii K, Goldman EH, Park HR, Zhang L, Chen J, Fu H. 2004. Negative control of apoptosis signal-regulating kinase-1 through phosphorylation of Ser-1034. Oncogene 23:5099-5104.
7. Green DR, Reed JC. 1998. Mitochondria and apoptosis. Science 281:1309-1312.
8. Heinrichsdorff J, Luedde T, Perdiguero E, Nebreda AR, Pasparakis M. 2008. p38a MAPK inhibits JNK activation and collaborates with IκB kinase 2 to prevent endotoxin-induced liver failure. EMBO Rep 9:1048-1054.
9. Hengartner MO. 2000. The biochemistry of apoptosis. Nature 407:700-706.
10. Hochhaus A, Kreil S, Corbin AS, La Rosee P, Muller MC, Lahaye T, Hanfstein B, Schoch C, Cross NC, Berger U, Gschaidmeier H, Druker BJ, Hehlmann R. 2002. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia 16:2190-2196.
11. Junttila MR, Li SP, Westermarck J. 2008. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 22:954-965.
12. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A, Green DR. 1998. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol Cell 1:543-551.
13. Krishna M, Narang H. 2008. The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell Mol Life Sci 65:3525-3544.
14. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, Young PR. 1997. Novel homologues of CSBP/p38 MAP kinase activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235:533-538.
15. Kuo WH, Chen JH, Lin HH, Chen BC, Hsu JD, Wang CJ. 2005. Induction of apoptosis in the lung tissue from rats exposed to cigarette smoke involves p38/JNK MAPK pathway. Chem Biol Interact 155:31-42.
16. Lambeau G, Gelb MH. 2008. Biochemistry and physiology of mammalian secreted phospholipases A2. Annu Rev Biochem 77:495-520.
17. Lee SJ, Kim MS, Park JY, Woo JS, Kim YK. 2008. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis via JNK-mediated mitochondrial pathway in osteoblastic cells. Toxicology 248:121-129.
18. 2-treated U937 cells. J Cell Physiol 219:642-651.
19. McCubrey JA, Steelman LS, Abrams SL, Bertrand FE, Ludwig DE, Basecke J, Libra M, Stivala F, Milella M, Tafuri A, Lunghi P, Bonati A, Martelli AM. 2008. Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. Leukemia 22:708-722.
20. 2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radical Biol Med 40:376-387.
21. Reed JC. 2006. Proapoptotic multidomain Bcl-2/Bax-family protein: Mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ 13:1378-1386.
22. Schneider E, Cowan KH, Bader H, Toomey S, Schwartz GN, Karp JE, Burke PJ, Kaufmann SH. 1995. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 85:186-193.
23. Scholl C, Gilliland G, Frohling S. 2008. Deregulation of signaling pathways in acute myeloid leukemia. Semin Oncol 35:336-345.
24. Schroeter H, Boyd CS, Ahmed R, Spencer JP, Duncan RF, Rice-Evans C, Cadenas E. 2003. c-Jun N-terminal kinase (JNK)-mediated modulation of brain mitochondria function: New target proteins for JNK signalling in mitochondrion-dependent apoptosis. Biochem J 372:359-369.
25. 2 in central nervous system: Implications for neurodegenerative diseases. J Lipid Res 45:205-213.
26. 2 in oxidative and inflammatory responses in neurodegenerative diseases. J Neurochem 103:1-16.
27. 2 and apoptosis. Biochim Biophys Acta 1585:72-76.
28. Testa U, Riccioni R. 2007. Deregulation of apoptosis in acute myeloid leukemia. Haematologica 92:81-94.
29. Thorburn A. 2004. Death receptor-induced cell killing. Cell Signal 16:139-144.
30. 2. Biochim Biophys Acta 1761:1289-1300.
31. Van Etten RA. 2007. Aberrant cytokine signaling in leukemia. Oncogene 26:6738-6749.
32. Wang ZY. 2003. Ham-Wasserman lecture: Teatment of acute leukemia by inducing differentiation and apoptosis. Hematology 1:1-13.
33. Wu J, Wong WL, Khosravi F, Minden MD, Penn LZ. 2004. Blocking the Raf/ MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis. Cancer Res 64:6461-6468.
34. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
35. 2/M. Mol Cell Biol 19:8469-8478.